Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Cadonilimab plus chemotherapy in PD-L1-low gastroesophageal cancer: a bispecific opportunity?
Journal: Journal of gastrointestinal oncology
Published: June 21, 2026
NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutated.
Journal: Cancer chemotherapy and pharmacology
Published: May 14, 2025
Q-TWiST analysis of first-line nivolumab plus chemotherapy versus chemotherapy in patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma from CheckMate 649: 4-year follow-up results.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: February 10, 2025
Advances in Immunotherapy in Hepatocellular Carcinoma.
Journal: International journal of molecular sciences
Published: December 20, 2024
Liposomal eribulin (E7389-LF) plus nivolumab: a potential treatment option for patients with advanced gastric cancer?
Journal: Journal of gastrointestinal oncology
Published: June 01, 2024
Race/ethnicity and socioeconomic position in emergency department utilization in patients with hepatocellular carcinoma.
Journal: Future oncology (London, England)
Published: April 19, 2024
Complete Pathologic Response to Gemcitabine and Oxaliplatin Chemotherapy After Prior Therapies in a Patient With Hepatocellular Carcinoma and Peritoneal Metastases Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Journal: World journal of oncology
Published: February 10, 2024
Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma.
Journal: Radiation oncology (London, England)
Published: December 08, 2023
Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma: results from two expansion cohorts of a multicentre, open-label, phase 1b trial (COSMIC-021).
Journal: EClinicalMedicine
Published: September 08, 2023
Genomic characterization of early-stage hepatocellular carcinoma patients with Hepatitis B using circulating tumor DNA.
Journal: Clinics and research in hepatology and gastroenterology
Published: March 10, 2023
Last Updated: 09/26/2026